Table 1. Clinical factors associated with overall survival.
Patients
|
||||
---|---|---|---|---|
Characteristics | No. | Percentage | MST (Months) | P Log-rank test |
Age, years (median: 57; range: 30–80) | ||||
<57 | 36 | 47.4 | 15.7 | 0.943 |
⩾57 | 40 | 52.6 | 10.7 | |
Sex | ||||
Male | 56 | 73.7 | 11.5 | 0.780 |
Female | 20 | 26.3 | 11.7 | |
ECOG PS | ||||
0–1 | 62 | 81.6 | 11.8 | 0.020 |
2 | 14 | 18.4 | 8.1 | |
Initial staging | ||||
III | 37 | 48.7 | 19.2 | < 0.001 |
IV | 39 | 51.3 | 9.6 | |
Grading | ||||
G2 | 20 | 26.3 | 10.7 | 0.972 |
G3 | 56 | 73.7 | 11.8 | |
Site of tumour | ||||
Proximal stomach | 28 | 36.8 | 9.8 | 0.45 |
Distal stomach | 42 | 55.3 | 12.2 | |
Whole stomach | 6 | 7.9 | 11.3 | |
No.of sites involved a | ||||
0–1 | 49 | 64.5 | 16.9 | 0.004 |
⩾2 | 27 | 35.5 | 7.6 |
Abbreviation: MST: median survival time.
Sites involved: lymph nodes, liver, pancreas, peritoneum, lung, pleura.